Merck’s commitment to continue its presence in Iran

Author:
Actoverco
Date:
21 April 2019
11

Paolo Carly’s speech, General Manager of German Merck Company in the Middle East and North Africa at the inauguration of the new Actoverco Solid Drug Production Plant (Actoverco 2)

Paolo Carly’s speech, General Manager of German Merck Company in the Middle East and North Africa at the inauguration of the new Actoverco Solid Drug Production Plant (Actoverco 2):

According to Actoverco’s Public Relations, Paolo Carly said: “We are committed to not stop our activities in Iran.”

We also request from the Iranian Ministry of Health to be consistent in its policies. We are just at the beginning of cooperation with Actoverco, and the level of cooperation between Merck and Actoverco will increase in the fields of chemical and biotech drugs.

Reference: PHANA

Related Posts

HY6A3173

Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement

20240613_125328

20th Congress of Gynecologists and Obstetricians

لانچ داروی دیابت اکتوورکو (1)

The combined diabetes medicine was produced by Iranian scientists!

actover news-min

Actoverco launches diabetes drug “Trytis”

labour day

“International Labour Day”